Part of Reliance group
Netmeds
Latest, :
Latest moves
Our read of each move first, where we have one; what the report said is marked Reported.
Background
From 7 stories, the newest dated 3 Oct 2026. Summary written 7 Oct 2026.
Netmeds is an online pharmacy in India that is backed by Reliance. [1] source: Entrackr
Show 3 more paragraphs and 7 sources
Reliance Industries acquired a 60% stake in Netmeds for around Rs 620 crore. [2] source: YourStory Moneycontrol traced the acquisition to 2020 and described it as part of a push into India's e-pharmacy market. [3] source: Moneycontrol
Netmeds reported FY26 revenue from operations of Rs 44.7 crore, up 2.3 percent from Rs 43.7 crore in FY25. Profit was Rs 5.5 crore, about 5 percent lower year-on-year. [4] source: Indian Retailer Sales of goods rose 24 percent to Rs 6.03 crore. [4] source: Indian Retailer Entrackr reported in September 2026 that advertising and promotional expenditure rose 76% to Rs 2.9 crore. [1] source: Entrackr Medianama put FY26 operating revenue at Rs 44.69 crore against Rs 43.72 crore, with profit down 4% to Rs 5.53 crore. [5] source: Medianama Consumer complaints against Netmeds numbered 19,895 in 2025 versus 17,440 in 2024. [5] source: Medianama[6] source: Business Today
PharmEasy, Tata 1mg and Apollo 24/7 appear alongside Netmeds in e-pharmacy results reporting. [4] source: Indian Retailer Tata 1mg's FY26 revenue rose 23% to Rs 2,936 crore. [7] source: Entrackr
Sources
Questions about Netmeds
Who owns Netmeds?
Reliance Industries owns a majority of Netmeds, having acquired a 60% stake for around Rs 620 crore. Entrackr describes Netmeds as a Reliance-backed online pharmacy. [1] source: Entrackr[2] source: YourStory
How fast is Netmeds growing in India?
Netmeds reported FY26 revenue from operations of Rs 44.7 crore, up 2.3 percent from Rs 43.7 crore in FY25, while profit was Rs 5.5 crore, about 5 percent lower. [4] source: Indian Retailer
More stories about Netmeds
Stories that mention Netmeds
2 stories
Netmeds is named in these stories but is not their subject.